Masaoki Ito
Impact in
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Gastric Cancer Management and Outcomes
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
- HER2/EGFR in Cancer Research
- Lung Cancer Research Studies
Papers in
-
- Lung Cancer Treatments and Mutations 32
- Lung Cancer Diagnosis and Treatment 18
- Oncology 10
- Cancer Immunotherapy and Biomarkers 4
- Lung Cancer Research Studies 4
- Cancer Cells and Metastasis 2
- Co-authors
- Yoshihiro Miyata (28 shared papers)Morihito Okada (23 shared papers)Yasuhiro Tsutani (29 shared papers)Rafael Rosell (21 shared papers)Niki Karachaliou (12 shared papers)Keizo Misumi (6 shared papers)Jillian Wilhelmina Paulina Bracht (8 shared papers)Jordi Codony‐Servat (12 shared papers)
In The Last Decade
Masaoki Ito
63 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 58
- Pulmonary and Respiratory Medicine 616
- Oncology 183
- Cancer Research 81
- Molecular Biology 167
- Immunology and Allergy 13
Countries citing papers authored by Masaoki Ito
This map shows the geographic impact of Masaoki Ito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masaoki Ito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masaoki Ito more than expected).
Fields of papers citing papers by Masaoki Ito
This network shows the impact of papers produced by Masaoki Ito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masaoki Ito. The network helps show where Masaoki Ito may publish in the future.
Co-authors
The 25 scholars most cited alongside Masaoki Ito, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 68 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 101 | |
| 2 | 2018 | 71 | |
| 3 | 2021 | 67 | |
| 4 | 2017 | 59 | |
| 5 | 2017 | 49 | |
| 6 | 2017 | 41 | |
| 7 | 2019 | 41 | |
| 8 | 2020 | 40 | |
| 9 | 2014 | 39 | |
| 10 | 2018 | 38 | |
| 11 | 2021 | 36 | |
| 12 | 2019 | 35 | |
| 13 | 2023 | 31 | |
| 14 | 2014 | 23 | |
| 15 | 2018 | 23 | |
| 16 | 2019 | 22 | |
| 17 | 2023 | 22 | |
| 18 | 2016 | 21 | |
| 19 | 2022 | 21 | |
| 20 | 2022 | 16 |
About Masaoki Ito
Masaoki Ito is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Molecular Biology and Endocrine and Autonomic Systems, having authored 68 papers that have together received 1.1k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (32 papers), Lung Cancer Diagnosis and Treatment (18 papers), Cancer Immunotherapy and Biomarkers (4 papers), Lung Cancer Research Studies (4 papers), Protein Kinase Regulation and GTPase Signaling (3 papers), Nausea and vomiting management (2 papers), Cancer Cells and Metastasis (2 papers) and Regulation of Appetite and Obesity (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (616 citations), Oncology (183 citations), Cancer Research (81 citations), Molecular Biology (167 citations) and Immunology and Allergy (13 citations). Masaoki Ito has collaborated with scholars based in Japan, Spain and Italy. Frequent co-authors include Yoshihiro Miyata, Morihito Okada, Yasuhiro Tsutani, Rafael Rosell, Niki Karachaliou, Keizo Misumi, Jillian Wilhelmina Paulina Bracht, Jordi Codony‐Servat, Jordi Berenguer and Morihito Okada. Their work appears in journals such as Clinical Lung Cancer, Translational Lung Cancer Research, Lung Cancer, EBioMedicine and European Journal of Cardio-Thoracic Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.